Peripheral blood lymphocyte and monocyte recovery and survival in acute leukemia postmyeloablative allogeneic hematopoietic stem cell transplant

Biology of Blood and Marrow Transplantation

Volumn 18, Issue 4, 2012, Pages 600-607

  Thoma, Mary D ^a   Huneke, Tanya J ^a   DeCook, Lori J ^a   Johnson, Nicci D ^a   Wiegand, Rob A ^a   Litzow, Mark R ^a   Hogan, William J ^a   Porrata, Luis F ^a   Holtan, Shernan G ^a  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

Acute leukemia; Allogeneic transplant; Immune reconstitution; Lymphocyte; Monocyte; Myeloablative

Indexed keywords

BUSULFAN; CALCINEURIN INHIBITOR;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER SURVIVAL; CELL COUNT; CELL SURVIVAL; COHORT ANALYSIS; CORRELATION ANALYSIS; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MONOCYTE; MORTALITY; MYELOABLATIVE CONDITIONING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERIPHERAL LYMPHOCYTE; PROGNOSIS; RELAPSE; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; CELL COUNT; CLUSTER ANALYSIS; DISEASE-FREE SURVIVAL; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, MYELOID, ACUTE; LONGITUDINAL STUDIES; LYMPHOCYTES; MALE; MIDDLE AGED; MONOCYTES; MYELOABLATIVE AGONISTS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; TIME FACTORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 84858059022     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2011.08.007     Document Type: Article

References (31)

1. Pavletic Z.S., Joshi S.S., Pirruccello S.J., et al. Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematologic malignancies. Bone Marrow Transplant 1998, 21:33-41.
2. Kumar S., Chen M.G., Gastineau D.A., et al. Effect of slow lymphocyte recovery and type of graft-versus-host disease prophylaxis on relapse after allogeneic bone marrow transplantation for acute myelogenous leukemia. Bone Marrow Transplant 2001, 28:951-956.
3. Kumar S., Chen M.G., Gastineau D.A., et al. Lymphocyte recovery after allogeneic bone marrow transplantation predicts risk of relapse in acute lymphoblastic leukemia. Leukemia 2003, 17:1865-1870.
4. Kim D.H., Sohn S.K., Won D.I., Lee N.Y., Suh J.S., Lee K.B. Rapid helper T-cell recovery above 200 × 10 6/l at 3 months correlates to successful transplant outcomes after allogeneic stem cell transplantation. Bone Marrow Transplant 2006, 37:1119-1128.
5. Heining C., Spyridonidis A., Bernhardt E., et al. Lymphocyte reconstitution following allogeneic hematopoietic stem cell transplantation: a retrospective study including 148 patients. Bone Marrow Transplant 2007, 39:613-622.
6. Le Blanc K., Barrett A.J., Schaffer M., et al. Lymphocyte recovery is a major determinant of outcome after matched unrelated myeloablative transplantation for myelogenous malignancies. Biol Blood Marrow Transplant 2009, 15:1108-1115.
7. Matthews K., Lim Z., Pearce L., et al. Rapid recovery of lymphocyte subsets is not associated with protection from relapse of myelodysplastic syndromes and acute myeloid leukaemia after haematopoietic stem cell transplantation using a reduced intensity conditioning regimen and alemtuzumab. Br J Haematol 2010, 149:879-889.
8. Buhlmann L., Buser A.S., Cantoni N., et al. Lymphocyte subset recovery and outcome after T-cell replete allogeneic hematopoietic SCT. Bone Marrow Transplant 2010 Nov 29, [Epub ahead of print].
9. Burke M.J., Vogel R.I., Janardan S.K., et al. Early Lymphocyte recovery and outcomes after umbilical cord blood transplantation (UCBT) for hematologic malignancies. Biol Blood Marrow Transplant 2011, 17:831-840.
10. Barrett A.J., Savani B.N. Does chemotherapy modify the immune surveillance of hematological malignancies?. Leukemia 2009, 23:53-58.
11. Biswas S.K., Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol 2010, 11:889-896.
12. Morecki S., Gelfand Y., Yacovlev E., Eizik O., Shabat Y., Slavin S. CpG-induced myeloid CD11b+Gr-1+ cells efficiently suppress T cell-mediated immunoreactivity and graft-versus-host disease in a murine model of allogeneic cell therapy. Biol Blood Marrow Transplant 2008, 14:973-984.
13. Hoechst B., Gamrekelashvili J., Manns M.P., Greten T.F., Korangy F. Plasticity of human Th17 cells and iTregs is orchestrated by different subsets of myeloid cells. Blood 2011, 117:6532-6541.
14. Cox C.J., Habermann T.M., Payne B.A., Klee G.G., Pierre R.V. Evaluation of the Coulter Counter model S-Plus IV. Am J Clin Pathol 1985, 84:297-306.
15. Glucksberg H., Storb R., Fefer A., et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974, 18:295-304.
16. Kaplan E., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958, 53:457-481.
17. Garcia-Vidal C., Upton A., Kirby K.A., Marr K.A. Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: biological risk factors for infection according to time after transplantation. Clin Infect Dis 2008, 47:1041-1050.
18. Parody R., Martino R., Sanchez F., Subira M., Hidalgo A., Sierra J. Predicting survival in adults with invasive aspergillosis during therapy for hematological malignancies or after hematopoietic stem cell transplantation: single-center analysis and validation of the Seattle, French, and Strasbourg prognostic indexes. Am J Hematol 2009, 84:571-578.
19. Garcia M.R., Ledgerwood L., Yang Y., et al. Monocytic suppressive cells mediate cardiovascular transplantation tolerance in mice. J Clin Invest 2010, 120:2486-2496.
20. Ino K., Ageitos A.G., Singh R.K., Talmadge J.E. Activation-induced T cell apoptosis by monocytes from stem cell products. Int Immunopharmacol 2001, 1:1307-1319.
21. Porrata L.F., Inwards D.J., Ansell S.M., et al. Day 15 peripheral blood lymphocyte/monocyte ratio post-autologous peripheral hematopoietic stem cell transplantation and survival in diffuse large B-cell lymphoma. J Clin Oncol 2011, 29(Suppl):2011. abstr 8018.
22. Yanada M., Matsuo K., Suzuki T., Naoe T. Allogeneic hematopoietic stem cell transplantation as part of postremission therapy improves survival for adult patients with high-risk acute lymphoblastic leukemia: a metaanalysis. Cancer 2006, 106:2657-2663.
23. Horowitz M.M., Gale R.P., Sondel P.M., et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990, 75:555-562.
24. Pidala J., Lee S.J., Quinn G., Jim H., Kim J., Anasetti C. Variation in management of immune suppression after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2011.
25. Gooley T.A., Chien J.W., Pergam S.A., et al. Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med 2010, 363:2091-2101.
26. Lin M.T., Tseng L.H., Frangoul H., et al. Increased apoptosis of peripheral blood T cells following allogeneic hematopoietic cell transplantation. Blood 2000, 95:3832-3839.
27. Poulin J.F., Sylvestre M., Champagne P., et al. Evidence for adequate thymic function but impaired naive T-cell survival following allogeneic hematopoietic stem cell transplantation in the absence of chronic graft-versus-host disease. Blood 2003, 102:4600-4607.
28. Matsuoka K., Kim H.T., McDonough S., et al. Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation. J Clin Invest 2010, 120:1479-1493.
29. Coenen J.J., Koenen H.J., van Rijssen E., et al. Rapamycin, not cyclosporine, permits thymic generation and peripheral preservation of CD4+ CD25+ FoxP3+ T cells. Bone Marrow Transplant 2007, 39:537-545.
30. Lee K.H., Choi S.J., Lee J.H., et al. Prognostic factors identifiable at the time of onset of acute graft-versus-host disease after allogeneic hematopoietic cell transplantation. Haematologica 2005, 90:939-948.
31. Muller A.M., Linderman J.A., Florek M., Miklos D., Shizuru J.A. Allogeneic T cells impair engraftment and hematopoiesis after stem cell transplantation. Proc Natl Acad Sci USA 2010, 107:14721-14726.